Vertex Pharmaceuticals (VRTX) Cash & Equivalents (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.03% |
| Dec 31, 2025 | 2.94% |
| Sep 30, 2025 | -0.66% |
| Jun 30, 2025 | 6.36% |
| Mar 31, 2025 | 2.30% |
| Dec 31, 2024 | -12.78% |
| Sep 30, 2024 | 14.39% |
| Jun 30, 2024 | -49.99% |
| Mar 31, 2024 | -11.68% |
| Dec 31, 2023 | -6.67% |
| Sep 30, 2023 | 9.45% |
| Jun 30, 2023 | 9.27% |
| Mar 31, 2023 | -11.56% |
| Dec 31, 2022 | 14.53% |
| Sep 30, 2022 | 5.39% |
| Jun 30, 2022 | 14.50% |
| Mar 31, 2022 | 11.85% |
| Dec 31, 2021 | 8.27% |
| Sep 30, 2021 | 3.50% |
| Jun 30, 2021 | -3.82% |
| Mar 31, 2021 | 5.28% |
| Dec 31, 2020 | 11.76% |
| Sep 30, 2020 | 10.90% |
| Jun 30, 2020 | 34.45% |
| Mar 31, 2020 | 15.57% |
| Dec 31, 2019 | -8.49% |
| Sep 30, 2019 | 3.13% |
| Jun 30, 2019 | 13.85% |
| Mar 31, 2019 | 9.20% |
| Dec 31, 2018 | 6.93% |
| Sep 30, 2018 | 15.52% |
| Jun 30, 2018 | 7.49% |
| Mar 31, 2018 | 19.84% |
| Dec 31, 2017 | 20.25% |
| Sep 30, 2017 | 13.23% |
| Jun 30, 2017 | 2,644.66% |
| Mar 31, 2017 | -96.24% |
| Dec 31, 2016 | 64.51% |
| Sep 30, 2016 | 18.79% |
| Jun 30, 2016 | 0.27% |